Pure red cell aplasia as first manifestation of splenic marginal zone lymphoma-successful treatment with rituximab: a case report
Athanasios Anastasiadis(Democritus University of Thrace), Constantinos Tsatalas(Democritus University of Thrace), Ιoannis Kotsianidis(Democritus University of Thrace), Emmanouil Spanoudakis(Democritus University of Thrace), Dimitrios Margaritis(Democritus University of Thrace), Anna Christoforidou(University of Crete), Ioannis Kostopoulos(Aristotle University of Thessaloniki)
Cited by 3
Related Papers
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
|Nature Medicine|2020|633
Primary Treatment of Waldenström Macroglobulinemia With Dexamethasone, Rituximab, and Cyclophosphamide
|Journal of Clinical Oncology|2007|279
Primary gastrointestinal non-Hodgkin's lymphoma: A clinicopathologic study of 128 cases in Greece. A Hellenic Cooperative Oncology Group study (HeCOG)
|Leukemia & lymphoma/Leukemia and lymphoma|2006|160